Gavin Wood Insider Profile
4 Followers
Gavin Wood, CFO at Adaptimmune Therapeutics, holds 0.00 shares in Adaptimmune Therapeutics (Ticker: ADAPY), holds 125.21K shares in Affymetrix (Ticker: AFFX).
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-31.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Gavin Wood does not currently own shares as a corporate insider.
A breakdown of Gavin Wood's holdings
Insider Roles
CFO
Roles that Gavin Wood holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 16, 2020 - Dec 16, 2021
Return:-17.00%
The most profitable trade made by Gavin Wood
Gavin Wood's Trading History
Adaptimmune Therapeutics
Sep 03, 2025
CFO
Uninformative Sell
―
$0.00
Affymetrix
Apr 01, 2016
―
Uninformative Sell
―
$1.75M
List of latest transactions for each holding click on a transaction to see Gavin Wood's performance on stock
You May Also Like
Gavin Wood insider profile FAQ
What is the percentage of profitable transactions made by Gavin Wood?
The percentage of profitable transactions made by Gavin Wood is 0%.
What is the average return per transaction made by Gavin Wood?
The average return per transaction made by Gavin Wood is -31.20%.
What stocks does Gavin Wood hold?
Gavin Wood holds: ADAPY, AFFX stocks.
What was Gavin Wood’s latest transaction?
Gavin Wood latest transaction was an Uninformative Sell of ―.
What was Gavin Wood's most profitable transaction?
Gavin Wood’s most profitable transaction was an Informative Buy of ADAPY stock on December 16, 2020. The return on the trade was -17.00%.
What is Gavin Wood's role in Adaptimmune Therapeutics?
Gavin Wood's role in Adaptimmune Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.